KWAN, Min-fun, Rudolf,KRAMER, E., Douglas,FETTERLY, Geralk, J.,HUNG, Cheung-tak,JACKSON, Christopher Glyn Charles, Alexander,GLUE, Paul, William
申请号:
HK18115067
公开号:
HK1256017A1
申请日:
2018.11.26
申请国别(地区):
HK
年份:
2019
代理人:
摘要:
The application pertains to pharmaceutical combinations of orally administered paclitaxel and a P-gp inhibitor. The pharmaceutical combinations are suitable for the treatment of cancer in a subject and for reducing or preventing toxicity, hypersensitivity-type infusion reactions, and other negative outcomes resulting from or associated with intravenously administered paclitaxel (e.g., Taxol® or paclitaxel formulated with Cremophor®) therapy in a subject suffering from cancer.